Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-09-30 4:59 pm Purchase | 2025-07-21 | 13D | Mangoceuticals, Inc. MGRX | Jacob D. Cohen | 2,044,356 14.600% | 1,122,690 (+121.81%) | Filing History |
| 2025-04-11 5:00 pm Purchase | 2025-04-10 | 13D | Mangoceuticals, Inc. MGRX | Jacob D. Cohen | 921,666 11.000% | 921,666 (New Position) | Filing History |
| 2025-01-22 5:28 pm Purchase | 2024-12-13 | 13G | Mangoceuticals, Inc. MGRX | Greenfield Investments, Ltd | 515,000 14.440% | 515,000 (New Position) | Filing History |
| 2024-08-27 7:45 pm Purchase | 2024-08-26 | 13D | Mangoceuticals, Inc. MGRX | Jacob D. Cohen | 721,667 34.200% | 16,667 (+2.36%) | Filing History |
| 2024-06-05 5:15 pm Purchase | 2024-06-03 | 13D | Mangoceuticals, Inc. MGRX | Jacob D. Cohen | 705,000 34.700% | 53,333 (+8.18%) | Filing History |
| 2023-12-29 9:51 pm Purchase | 2023-12-28 | 13D | Mangoceuticals, Inc. MGRX | Jacob D. Cohen | 651,667 42.600% | 100,000 (+18.13%) | Filing History |
| 2023-05-02 8:55 pm Purchase | 2023-04-10 | 13D | Mangoceuticals, Inc. MGRX | Jacob D. Cohen | 551,667 47.800% | 551,667 (New Position) | Filing History |